SCHEMBL7094762

SCHEMBL7094762

Cc1c2c(c(C)c3c1OC(=O)C3)OC(=O)C2

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10000753 0.71 PIM1 (0.32)
SCHEMBL12244033 0.67
SCHEMBL313621 0.65
SCHEMBL19297208 0.64 RECQL (0.45) KDM4EALDH1A1HPGD
SCHEMBL4459202 0.63 TSHR (0.45) TSHR
SCHEMBL19297112 0.63 RECQL (0.39)
SCHEMBL979977 0.61
SCHEMBL21605346 0.60 MAPT (0.38) KDM4EALDH1A1HPGD
SCHEMBL15763923 0.59 TSHR (0.32) TSHR
SCHEMBL7685523 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115651448-B Conductive ink with n-type conductivity and preparation and application thereof 华南理工大学 2024-04-09 CN disclosed
CN-115651448-A Conductive ink with n-type conductivity and preparation and application thereof 华南理工大学 2023-01-31 CN disclosed
US-20030121113-A1 Oxobenzofuranylide-dihydroindolone NESVADBA PETER (CH) 2003-07-03 US disclosed
US-6503937-B1 Coloring agents for high molecular weight materials such as polymers CIBA SPECIALTY CHEMICALS CORPORATION 2003-01-07 US disclosed
EP-1123289-B1 OXOBENZOFURANYLIDE-DIHYDROINDOLONES CIBA SC HOLDING AG (CH) 2002-11-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030121113-A1 Oxobenzofuranylide-dihydroindolone CYP1B1, CYP1A1, ECI1 KDM4E 4543/4885ALDH1A1 225/4885HPGD 257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.